• Upper respiratory tract infections
• common cold
Each tablet contains dry extract of:
Fresh organically grown* Echinacea (Echinacea purpurea)
Herb (ratio 5:1) ...6.35 mg, equivalent to 31.7 mg of organically grown* dried herb;
Root (ratio 5.5:1) ...0.33 mg, equivalent to 1.8 mg of organically grown* dried root.
Sorbitol, cyclodextrin, colloidal silicon dioxide, natural orange flavour, vegetable magnesium stearate.
Helps relieve symptoms of upper respiratory tract infections (i.e. common cold). Shortens the duration of upper respiratory tract infections. Helps to prevent upper respiratory tract infections such as flu-like episodes and the common cold. Used in Herbal Medicine to support the immune system, especially in times of stress and lack of sleep. Clinically shown to help relieve the symptoms of minor upper respiratory tract infections such as the common cold. Clinically shown to help prevent cold episodes (upper respiratory tract infections) Take at the first sign of infection.
15 minutes before meals:
Children 2 to 4 years old: Chew 1 tablet, once daily.
Children 2 to 4 years old:
Chew 1 tablet, 1-2 x daily;
Children 5 to 9 years old: Chew 1 tablet, twice daily.
Children 5 to 9 years old: Chew 1 tablet, 2-3 x daily
Duration of use: May be used for up to 4 months.
If symptoms persist or worsen, consult a health care practitioner. If you are taking immunosuppressants, consult a health care practitioner. If you have an autoimmune disorder consult a health care practitioner prior to use. If you have a progressive systemic disease, such as tuberculosis, collagenosis, multiple sclerosis, AIDS and / or HIV infection, consult a health care practitioner prior to use. Rare cases of severe allergic reactions have been known to occur; use caution if you are allergic to plants of the Daisy family.
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Do not use if security cap is broken. Keep out of reach of children.
1. Burger Ra, Torres AR, Warren RP et al. Echinacea-induced cytokine by human macrophages. Int J Immunopharmacol 1997;19(7):371-9.
2. Lin Z, Neamati N, Zhao H et al. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem 1999;42(8):1401-14.
3. Gunning K. Echinacea in the treatment and prevention of upper respiratory tract infections. West J Med 1999;171:198-200.
4. Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35.
5. Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999;106:138-43.
6. Barrett B, Vohmann M et Calabrese C. Echinacea for Upper respiratory infection. J Fam Pract 1999;48(8):628-35.
7. Brinkeborn RM, Shah DV, Degenring FH. Echinaforce® and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. Phytomedicine 1999 Mar;6(1):1-6
8. Brinkeborn RM, Shah DV, GeissbÜhler S, Degenring FH. Echinaforce® dans le traitement des États grippaux aigus. Schweiz Zschr GanzheitsMedizin 1998;10(1):26-9.
9. Kim LS, Waters RF, Burkholder PM. Immunological activity of larch arabinogalactan and Echinacea: A preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev 2002 Apr;7(2):138-149
10. Gallo M, Sarkar M, Au W et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med 2000;160(20):3141-3
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.